Blog
Operationalizing patient centricity: Three key takeaways from IQVIA Innovation Day, SCOPE Summit 2025
Chris Driver, Senior Director, Product Management, IQVIA Technologies
Apr 03, 2025

Patient centricity has been a buzzword in clinical trials for years. Now, industry leaders are doing the hard work of defining what it means and how to operationalize it in their clinical trial programs. At the recent IQVIA Innovation Day held prior to the SCOPE Summit 2025, clinical operations leaders, investigative site representatives and patient advocacy groups gathered to discuss this concept and share actionable insights. Here, we detail three key takeaways from the discussions, identifying some of the latest ways to operationalize patient centricity in clinical trials.

1. Championing digital adoption: Enhancing ease of use and efficiency

In the past, the complexity of digital tools in clinical trials has presented challenges for patients, which can impact trial success — from data integrity to patient dropout. It’s time to raise the bar and deliver a consumer-grade technology experience to trial participants.

Industry experts emphasized ease of use: Technologies must be intuitive and easy to navigate to ensure that all participants, regardless of their tech-savviness, can use them. Pharma and tech companies should consider the reality of non-tech users when building solutions. Instead of focusing on creating the “best” technologies, companies need to refocus on the “why” and not the “what” in designing tech to effectively support clinical trials.

2. Enhancing patient experience: Building trust and transparency

In the clinical trial environment, building trust is key to successful outcomes. Roundtable participants agreed that gathering feedback from patients fosters trust and transparency, improves the user experience and drives compliance. Short surveys and questionnaires that keep questions unbiased were mentioned as ways to solicit patient perspectives.

The discussion echoed themes from the roundtable on digital adoption. Roundtable experts agreed that engaging with patients to identify and address their needs is not only critical to trial success but central to building better tech solutions. By focusing on these elements, clinical trials can benefit from a two-way interaction where patients feel valued and heard and feedback guides tech and trial improvements.

3. Raising awareness of clinical trials: Educating and engaging communities

Despite the many advancements in medical science, many patients remain unaware of the treatment and care options offered by clinical trials. In the panel discussion Actionable Strategies to Promote Diversity in Clinical Research Participation, panelists stressed the importance of raising awareness and education about clinical trials. They agreed that the first group to target is primary care providers.

In their discussion, they also acknowledged that sites are overwhelmed and the work of educating the broader population about clinical trials as a care option should not fall solely on their backs. One expert noted the importance of educating physicians — from primary care providers to specialists — so they can raise clinical trials as an option to their patients.

Experts emphasized the importance of caregivers and family members as partners in positioning clinical trials as a viable option for patients. Patient advocacy groups, community centers, family outreach sites and Federally Qualified Health Centers can each help identify patient needs and educate potential patients on trial options.

Looking forward: The future of patient-centric clinical trials

A truly patient-centric approach encompasses the entire clinical trial journey, from awareness and education to participation and post-trial engagement. Clinical trial design is a critical step to ensure trials are created with the participants’ needs and realities in mind. Reducing the need for site visits, as an example, by leveraging eCOAs rather than in-person diaries or connected devices to gather biometric data remotely can improve patient experience and trial outcomes. IQVIA has taken these concepts as foundational in designing trial solutions with the patient at the center. Our Patient Suite simplifies the complexity of trial participation and provides patients with a smooth and engaging trial experience.

As we look to the future, the insights from these Innovation Day discussions help provide actionable steps for more patient-centric clinical trials. By championing digital adoption, enhancing patient experience and raising awareness, IQVIA and others are helping sites and sponsors set new standards for patient centricity.

If you’d like to dive deeper into the topic of improving patient centricity, then please email us at orchestrateyourtrials@iqvia.com, and we’ll set up a conversation.

If you enjoyed this blog, then we suggest you read our companion piece that summarizes our discussion on the clinical site experience with Innovation Day attendees: Three ways to simplify site processes: Insights from industry leaders at IQVIA Innovation Day, SCOPE Summit 2025

Related solutions

Contact Us